An expert on aging thinks humans could live to be 1,000 years old-with a few tweaks to our genetic “software”

Researchers in the United States have shown that genes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the causative agent of coronavirus disease 2019 (COVID-19) - can be integrated into the genome of infected human cells. The team says the viral RNA can be expressed as chimeric transcripts with fused cellular and viral sequences.

TAMPA, Fla. - Immunotherapies have improved outcomes of many patients with cancer, including melanoma. But these therapies work for only a subset of patients. Numerous studies are looking at improving responses, including research focusing on enhancing tumor-infiltrating lymphocytes (TILs).

Pfizer's COVID-19 vaccine contains mRNA fragments called "truncated mRNA." This is a serious issue on top of the vaccine's life-threatening safety events. Stunningly, Pfizer submitted falsified mRNA analytical reports to multiple health authorities. The issue of truncated mRNA led the European Medicines Agency (EMA) to raise a "major objection" before its December 2020 conditional approval of the vaccine.

Scientists have created a new powerful "masked" cancer drug. Numerous cancer treatments are notoriously harsh on the body; they assault healthy cells simultaneously with tumor cells and result in a wide range of side effects. The Pritzker School of Molecular Engineering (PME) at the University of C

Daily Mail 06/07/2022 Mark Branagan For Mailonline A family has revealed how a 19-year-old girl died riddled with cancer after pleading in agony to see her doctor for more than a year. The family of Amelia Ellerby are demanding answers and have slammed GPs for using Covid-19 as 'an excuse' not to see patients.

Posted on 6 February 2020 New research has deciphered how rogue communications in blood stem cells can cause Leukaemia. The discovery could pave the way for new, targeted medical treatments that block this process. Blood cancers like leukaemia occur when mutations in stem cells cause them to produce too many blood cells.

Prof Sewell said the 'right people' are now interested in developing the potential new therapy and said progress could now move 'quite fast'. The team says human trials on terminally ill patients could begin as early as November if the new treatment passes further laboratory safety testing.